Cosmos Health to Distribute Virax Avian Influenza PCR Kits in Europe, GCC Countries

MT Newswires Live2025-01-13

Cosmos Health (COSM) said Monday it entered into a distribution agreement with Virax Biolabs (VRAX) to distribute Virax-branded Avian Influenza Virus Real-Time PCR Kits in major European and Gulf Cooperation Council markets.

Financial details weren't disclosed.

Cosmos Health secures exclusive distribution rights for the kits in Greece and Cyprus and non-exclusive rights in European markets, including France, Portugal, Spain, The Netherlands, Belgium, Sweden, Finland, Denmark, Norway, Germany, Switzerland, and Austria.

Cosmos Health said the non-exclusive rights also cover GCC countries Oman and Bahrain.

The agreement allows Cosmos Health to import, sell, and distribute ViraxClear-branded kits in the specified territories, with Virax Biolabs handling regulatory compliance and providing necessary documentation for product registration and approval.

Shares of Cosmos Health were down more than 6% in recent Monday trading, while Virax's were up 2.1%.

Price: 0.58, Change: -0.04, Percent Change: -6.15

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2503589965?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-01-13 23:24","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2503589965","market":"fut","top_or_hot":-1,"title":"Cosmos Health to Distribute Virax Avian Influenza PCR Kits in Europe, GCC Countries","media":"MT Newswires Live","content":"<html><body><p> Cosmos Health (COSM) said Monday it entered into a distribution agreement with Virax Biolabs (VRAX) to distribute Virax-branded Avian Influenza Virus Real-Time PCR Kits in major European and Gulf Cooperation Council markets.</p><p>Financial details weren't disclosed.</p><p>Cosmos Health secures exclusive distribution rights for the kits in Greece and Cyprus and non-exclusive rights in European markets, including France, Portugal, Spain, The Netherlands, Belgium, Sweden, Finland, Denmark, Norway, Germany, Switzerland, and Austria.</p><p>Cosmos Health said the non-exclusive rights also cover GCC countries Oman and Bahrain.</p><p>The agreement allows Cosmos Health to import, sell, and distribute ViraxClear-branded kits in the specified territories, with Virax Biolabs handling regulatory compliance and providing necessary documentation for product registration and approval.</p><p>Shares of Cosmos Health were down more than 6% in recent Monday trading, while Virax's were up 2.1%.</p><p>Price: 0.58, Change: -0.04, Percent Change: -6.15</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Cosmos Health to Distribute Virax Avian Influenza PCR Kits in Europe, GCC Countries</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCosmos Health to Distribute Virax Avian Influenza PCR Kits in Europe, GCC Countries\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-01-13 23:24</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Cosmos Health (COSM) said Monday it entered into a distribution agreement with Virax Biolabs (VRAX) to distribute Virax-branded Avian Influenza Virus Real-Time PCR Kits in major European and Gulf Cooperation Council markets.</p><p>Financial details weren't disclosed.</p><p>Cosmos Health secures exclusive distribution rights for the kits in Greece and Cyprus and non-exclusive rights in European markets, including France, Portugal, Spain, The Netherlands, Belgium, Sweden, Finland, Denmark, Norway, Germany, Switzerland, and Austria.</p><p>Cosmos Health said the non-exclusive rights also cover GCC countries Oman and Bahrain.</p><p>The agreement allows Cosmos Health to import, sell, and distribute ViraxClear-branded kits in the specified territories, with Virax Biolabs handling regulatory compliance and providing necessary documentation for product registration and approval.</p><p>Shares of Cosmos Health were down more than 6% in recent Monday trading, while Virax's were up 2.1%.</p><p>Price: 0.58, Change: -0.04, Percent Change: -6.15</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"COSM","symbol_name":"COSMOS HEALTH INC","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2503589965","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2503589965","pubTimestamp":1736781871,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Cosmos Health  said Monday it entered into a distribution agreement with Virax Biolabs  to distribute Virax-branded Avian Influenza Virus Real-Time PCR Kits in major European and Gulf Cooperation Council markets.Financial details weren't disclosed.Cosmos Health secures exclusive distribution rights for the kits in Greece and Cyprus and non-exclusive rights in European markets, including France, Portugal, Spain, The Netherlands, Belgium, Sweden, Finland, Denmark, Norway, Germany, Switzerland, and Austria.Cosmos Health said the non-exclusive rights also cover GCC countries Oman and Bahrain.The agreement allows Cosmos Health to import, sell, and distribute ViraxClear-branded kits in the specified territories, with Virax Biolabs handling regulatory compliance and providing necessary documentation for product registration and approval.Shares of Cosmos Health were down more than 6% in recent Monday trading, while Virax's were up 2.1%.Price: 0.58, Change: -0.04, Percent Change: -6.15","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"COSM":"COSMOS HEALTH INC","BK4583":"猴痘概念","VRAX":"Virax Biolabs Group Limited","BK4175":"保健护理产品经销商","GCC":"智慧树连续商品指数基金"},"translate_title":"Cosmos Health将在欧洲和海湾合作委员会国家分发Virax禽流感PCR试剂盒","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"VRAX":0.9,"GCC":1,"COSM":0.9},"content_text":"Cosmos Health (COSM) said Monday it entered into a distribution agreement with Virax Biolabs (VRAX) to distribute Virax-branded Avian Influenza Virus Real-Time PCR Kits in major European and Gulf Cooperation Council markets.Financial details weren't disclosed.Cosmos Health secures exclusive distribution rights for the kits in Greece and Cyprus and non-exclusive rights in European markets, including France, Portugal, Spain, The Netherlands, Belgium, Sweden, Finland, Denmark, Norway, Germany, Switzerland, and Austria.Cosmos Health said the non-exclusive rights also cover GCC countries Oman and Bahrain.The agreement allows Cosmos Health to import, sell, and distribute ViraxClear-branded kits in the specified territories, with Virax Biolabs handling regulatory compliance and providing necessary documentation for product registration and approval.Shares of Cosmos Health were down more than 6% in recent Monday trading, while Virax's were up 2.1%.Price: 0.58, Change: -0.04, Percent Change: -6.15","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2503589965","isCrawlerRequest":true}